Saving changes...

Done

Error

Practical experience of administering subcutaneous rituximab

Practical experience of administering subcutaneous rituximab

Practical experience of administering subcutaneous rituximab

Sarah Liptrott, Nicola Crosbie, Maris Stella Sugino, Renate Bratke, Maria Mendoza, and Pakeeza Sayye
Sarah Liptrott, Nicola Crosbie, Maris Stella Sugino, Renate Bratke, Maria Mendoza, and Pakeeza Sayye
on behalf of Royal College of Nursing

$30.00 $ 30.00 $ 30.00

$30.00 $ 30.00 $ 30.00

$ 30.00 $ 30.00 $ 30.00
$ 30.00 $ 30.00 $ 30.00
Normal Price: $30.00 $30.00

Review:

Launch date: 26 Jan 2018
Expiry Date:

Last updated: 27 Jul 2020

Reference: 186250

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

WILFRED NKHAMBULE (26 Jul 2020)
good learning experience
THOMAS KWIZERA (17 Jul 2020)
awesome!
Mrs JOYCE MBASU (15 Jul 2020)
Very informative

I would like to...

Description

Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has conventionally been given by intravenous (IV) infusion, which requires intermittent patient monitoring during administration. A subcutaneous (SC) formulation is also available for the treatment of NHL, which takes less time to administer and could simplify treatment. With the newer formulation available, there is an ongoing need for education and understanding from the patient’s and the healthcare professional’s perspective. The authors review their personal experience of rituximab IV and SC formulations together with data on their safety, and provide an overview of the use of SC formulation in daily nursing practice.

Objectives

After reading this module you should be able to:
• Describe how rituximab works in patients with non-Hodgkin lymphoma (NHL).
• Access the clinical guidance available for patient assessment and preparation for SC administration and understand how to administer the SC injection.
Sarah Liptrott, Nicola Crosbie, Maris Stella Sugino, Renate Bratke, Maria Mendoza, and Pakeeza Sayye

Author Information Play Video Bio

Sarah Liptrott, Nicola Crosbie, Maris Stella Sugino, Renate Bratke, Maria Mendoza, and Pakeeza Sayye
on behalf of Royal College of Nursing

Sarah Liptrott, Clinical research nurse, European Institute of Oncology, Milan, Italy.

Nicola Crosbie, Nurse clinician, Derriford Hospital, Plymouth Hospitals NHS Trust.

Maris Stella Sugino, Nurse clinician, Hospital das Clínicas da FMUSP, São Paulo, Brazil.

Renate Bratke, Nurse clinician, Technical University Munich, Germany.

Maria Mendoza, International scientific director, F Hoffmann-La Roche Ltd, Basel, Switzerland.

Pakeeza Sayyed, Senior clinical scientist, F Hoffmann-La Roche Ltd, Basel, Switzerland.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (22)

Go Back
WILFRED NKHAMBULE (26 Jul 2020)
good learning experience
THOMAS KWIZERA (17 Jul 2020)
awesome!
Mrs JOYCE MBASU (15 Jul 2020)
Very informative
JUDE MULANDI (3 Jul 2020)
Very educative
Isah Lami Dorcas (28 Jun 2020)
this course is good
Ayomide Ojegbeje (25 Jun 2020)
very good
Blessing Adibe (23 Jun 2020)
very good
COMFORT NZERUE (21 Jun 2020)
Wow! such amazing course, learnt much.
DENISE NIYIGABA (20 Jun 2020)
the module helps me to know SC
JOSIANE NIYONSENGA (17 Jun 2020)
very good
Miss Ngozichika Okeke Obiageli (31 May 2020)
good
HONORINE UMWANAWIMPUHWE (29 May 2020)
Thanks
Ibegbu Favour Joyce (27 May 2020)
good
Emily Mok (20 May 2020)
Simple and easy to understand
CHARLOTTE MUKAMAZIMPAKA (16 May 2020)
good
Mpiegbulam Chinyere (16 May 2020)
it refresh my knowledge
VALENTINE NYIRAMUGISHA (10 May 2020)
very good
IRENE NYANKESHA (29 Apr 2020)
was interest
Mrs Santana Ramdass-Ramkairsingh (27 Apr 2020)
This course was excellently executed in instructing an individual on retuximab and how to ensure proper use when it regards patients .
CAROLYNE KIM IYA (7 Apr 2020)
very informative
ILDEPHONSE HAKIZIMANA (4 Apr 2020)
hard working
Mrs Jodie Deakin (16 Sep 2018)
Brilliant resource for learning about Rituximab S/C.

Loading...


Saving changes...

Done

Error